文献速递前列腺癌男科与性医学

雄激素剥夺治疗与认知下降:脑连接组、内分泌状态及风险基因型的关联

Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2021-06-04

结果显示ADT患者睾酮降低且部分认知域下降率更高,COMT Met纯合子患者视空间记忆下降更明显,但脑连接组和睾酮变化未预测认知下降。

要点

  • ADT治疗6个月后前列腺癌患者睾酮水平显著降低(p<0.01)。
  • 15项认知结局中13项下降率高于健康对照,其中言语记忆和视空间学习与记忆达统计学显著(p≤0.01-0.04)。
  • COMT Met纯合子患者视空间记忆下降较Val携带者更大(p=0.02)。

核心结论

  • 接受ADT的前列腺癌患者可能出现认知下降,COMT Met纯合子可能风险更高。
  • 脑连接组和睾酮水平变化未显示为认知下降的潜在机制。

研究设计与样本

  • 在ADT前和治療6个月后行认知评估、结构MRI及血液样本采集。
  • 认知下降采用标准化回归方法判定,定义为z评分≤-1.64。

主要发现

  • 与健康对照相比,前列腺癌患者睾酮水平降低(p<0.01)。
  • 15项认知结局中13项下降率更高,其中3项涉及言语记忆和视空间学习与记忆两个认知域达统计学显著(p≤0.01-0.04)。
  • 睾酮水平变化未预测认知下降。
  • COMT Met纯合子前列腺癌患者视空间记忆下降较Val携带者更大(p=0.02)。
  • 脑连接组随时间未见组间差异,APOE和BDNF未见效应。

临床怎么用

  • 对接受ADT的前列腺癌患者应关注认知功能,尤其是言语记忆和视空间记忆。
  • COMT Met纯合子患者可考虑加强认知监测。

局限性

  • 随访仅6个月,长期认知变化未知。
  • 未发现脑连接组和睾酮变化作为机制,需进一步研究下丘脑-垂体-性腺轴动态紊乱的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence suggests that prostate cancer (PC) patients undergoing androgen deprivation therapy (ADT) are at risk for cognitive decline (CD), but the underlying mechanisms are less clear. In the present study, changes in cognitive performance and structural brain connectomes in PC patients undergoing ADT were assessed, and associations of cognitive changes with endocrine status and risk genotypes were explored. METHODS: Thirty-seven PC patients underwent cognitive assessment, structural MRI, and provided blood samples prior to ADT and after 6 months of treatment. Twenty-seven age- and education-matched healthy controls (HCs) underwent the same assessments. CD was determined using a standardized regression-based approach and defined as z-scores ≤ -1.64. Changes in brain connectomes were evaluated using graph theory. Associations of CD with testosterone levels and genotypes (APOE, COMT, BDNF) were explored. RESULTS: Compared with HCs, PC patients demonstrated reduced testosterone levels (p < 0.01) and higher rates of decline for 13 out of 15 cognitive outcomes, with three outcomes related to two cognitive domains, i.e., verbal memory and visuospatial learning and memory, reaching statistical significance (p ≤ 0.01-0.04). Testosterone level changes did not predict CD. COMT Met homozygote PC patients evidenced larger reductions in visuospatial memory compared with Val carriers (p = 0.02). No between-group differences were observed in brain connectomes across time, and no effects were found of APOE and BDNF. CONCLUSIONS: Our results indicate that PC patients undergoing ADT may evidence CD, and that COMT Met homozygotes may be at increased risk of CD. The results did not reveal changes in brain connectomes or testosterone levels as underlying mechanisms. More research evaluating the role of ADT-related disruption of the dynamics of the hypothalamic-pituitary-gonadal axis is needed.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Buskbjerg CR, Amidi A, Buus S, et al. Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes. Prostate Cancer Prostatic Dis. 2021. PMID: 34088994. doi:10.1038/s41391-021-00398-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。